VP CAO Jonathan Wygant sold 24,000 VCYT shares at $45.40 (worth $1.1M), reducing stake to 45.4K shares post-transaction
Jonathan Wygant, VP and Chief Accounting Officer, sold 24,000 shares of Veracyte at $45.40 on May 22, 2026, reducing his non-derivative holdings by 34.6% from 69.4K to 45.4K shares. The transaction value of $1.1M occurred near the stock's 52-week high of $50.71, and the sale is notable given the company's strong recent momentum (30-day return of +31.4%) and solid fundamentals including 16.0% annual revenue growth and a net income of $28.7M on $139.1M quarterly revenue. As a senior financial officer, Wygant's sale of this magnitude warrants investor attention to whether this reflects a scheduled vest-and-sell or discretionary rebalancing of his portfolio position, particularly in light of the elevated valuation environment reflected in the 40.45 P/E ratio.